This topic contains a solution. Click here to go to the answer

Author Question: Discuss the special considerations about services during the consumption stage of the consumer ... (Read 42 times)

Mr.Thesaxman

  • Hero Member
  • *****
  • Posts: 514
Discuss the special considerations about services during the consumption stage of the consumer decision process.

Question 2

When a firm possesses capabilities that allow it to serve customers' needs better than the competition, the firm is said to have a:
 A) resource advantage.
  B) competitive advantage.
  C) value-based advantage.
  D) marketing advantage.
  E) relative advantage.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blakeserpa

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

 No service can be produced or used with either the consumer or the service firm absent.


Due to the extended service delivery process, many believe that the consumer's postchoice evaluation occurs during and after, rather than just after, the use of services.


From a marketer's point of view, this provides the opportunity to directly influence that evaluation.


Due to the client-company interface, the service provider is able to catch problems and change evaluations in a way that the manufacturer of a packaged good cannot.

Answer to Question 2

B




Mr.Thesaxman

  • Member
  • Posts: 514
Reply 2 on: Jun 28, 2018
:D TYSM


cpetit11

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Excellent

 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library